Inhibition	B:C0021469
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	B:C0074321
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	B:C0026237
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	B:C0162638
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	B:C0227525
and	O
in	O
mice	O
.	O

Inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
protects	O
against	O
senecionine	O
-	O
induced	O
mitochondria	O
-	O
mediated	O
apoptosis	O
in	O
primary	O
hepatocytes	O
and	O
in	O
mice	B:C0026809
.	O

Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
(	O
Pyrrolizidine	O
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	O
found	O
in	O
various	O
plants	O
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	O
medicines	I:C2240391
and	O
food	O
supplements	I:C0242295
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
(	O
Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	O
found	O
in	O
various	O
plants	O
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	O
medicines	I:C2240391
and	O
food	O
supplements	I:C0242295
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
(	O
Pyrrolizidine	O
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	B:C0002062
found	O
in	O
various	O
plants	O
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	O
medicines	I:C2240391
and	O
food	O
supplements	I:C0242295
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
(	O
Pyrrolizidine	O
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	O
found	O
in	O
various	O
plants	B:C0032098
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	O
medicines	I:C2240391
and	O
food	O
supplements	I:C0242295
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
(	O
Pyrrolizidine	O
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	O
found	O
in	O
various	O
plants	O
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	B:C2240391
medicines	I:C2240391
and	O
food	O
supplements	I:C0242295
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
(	O
Pyrrolizidine	O
alkaloids	I:C0034335
)	O
are	O
a	O
group	O
of	O
compounds	O
found	O
in	O
various	O
plants	O
and	O
some	O
of	O
them	O
are	O
widely	O
consumed	O
in	O
the	O
world	O
as	O
herbal	O
medicines	I:C2240391
and	O
food	B:C0242295
supplements	I:C0242295
.	O

Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
are	O
potent	O
hepatotoxins	O
that	O
cause	O
irreversible	O
liver	O
injury	I:C0160390
in	O
animals	O
and	O
humans	O
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
are	O
potent	O
hepatotoxins	O
that	O
cause	O
irreversible	B:C0879537
liver	O
injury	I:C0160390
in	O
animals	O
and	O
humans	O
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
are	O
potent	O
hepatotoxins	O
that	O
cause	O
irreversible	O
liver	B:C0160390
injury	I:C0160390
in	O
animals	O
and	O
humans	O
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
are	O
potent	O
hepatotoxins	O
that	O
cause	O
irreversible	O
liver	O
injury	I:C0160390
in	O
animals	B:C0003062
and	O
humans	O
.	O

Pyrrolizidine	O
alkaloids	I:C0034335
are	O
potent	O
hepatotoxins	O
that	O
cause	O
irreversible	O
liver	O
injury	I:C0160390
in	O
animals	O
and	O
humans	B:C0086418
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
induce	O
liver	O
injury	I:C0160390
are	O
not	O
clear	O
.	O

However	O
,	O
the	O
mechanisms	O
by	O
which	O
Pyrrolizidine	O
alkaloids	I:C0034335
induce	O
liver	B:C0160390
injury	I:C0160390
are	O
not	O
clear	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	B:C0235378
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	B:C1258062
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	B:C0074321
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	B:C0032346
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	B:C0007585
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	B:C0026809
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	B:C0086418
hepatocytes	O
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	B:C0227525
as	O
well	O
as	O
in	O
mice	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
hepatotoxicity	O
and	O
molecular	O
mechanisms	I:C1258062
of	O
senecionine	O
,	O
one	O
of	O
the	O
most	O
common	O
toxic	O
Pyrrolizidine	O
alkaloids	I:C0034335
,	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocytes	O
as	O
well	O
as	O
in	O
mice	B:C0026809
.	O

We	O
found	O
that	O
senecionine	B:C0074321
administration	O
increased	O
serum	I:C0151905
alanine	I:C0151905
aminotransferase	I:C0151905
levels	I:C0151905
in	O
mice	O
.	O

We	O
found	O
that	O
senecionine	O
administration	B:C3469597
increased	O
serum	I:C0151905
alanine	I:C0151905
aminotransferase	I:C0151905
levels	I:C0151905
in	O
mice	O
.	O

We	O
found	O
that	O
senecionine	O
administration	O
increased	B:C0151905
serum	I:C0151905
alanine	I:C0151905
aminotransferase	I:C0151905
levels	I:C0151905
in	O
mice	O
.	O

We	O
found	O
that	O
senecionine	O
administration	O
increased	O
serum	I:C0151905
alanine	I:C0151905
aminotransferase	I:C0151905
levels	I:C0151905
in	O
mice	B:C0026809
.	O

H&E	B:C0523207
and	O
TUNEL	O
staining	I:C1515232
of	O
liver	O
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	O
and	O
hepatocyte	O
apoptosis	I:C3269241
in	O
liver	O
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

H&E	O
and	O
TUNEL	B:C1515232
staining	I:C1515232
of	O
liver	O
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	O
and	O
hepatocyte	O
apoptosis	I:C3269241
in	O
liver	O
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

H&E	O
and	O
TUNEL	O
staining	I:C1515232
of	O
liver	B:C0736268
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	O
and	O
hepatocyte	O
apoptosis	I:C3269241
in	O
liver	O
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

H&E	O
and	O
TUNEL	O
staining	I:C1515232
of	O
liver	O
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	B:C0019080
and	O
hepatocyte	O
apoptosis	I:C3269241
in	O
liver	O
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

H&E	O
and	O
TUNEL	O
staining	I:C1515232
of	O
liver	O
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	O
and	O
hepatocyte	B:C3269241
apoptosis	I:C3269241
in	O
liver	O
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

H&E	O
and	O
TUNEL	O
staining	I:C1515232
of	O
liver	O
tissues	I:C0736268
revealed	O
increased	O
hemorrhage	O
and	O
hepatocyte	O
apoptosis	I:C3269241
in	O
liver	B:C0507183
zone	I:C0507183
2	I:C0507183
areas	I:C0507183
.	O

Mechanistically	O
,	O
senecionine	B:C0074321
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	B:C1720920
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	B:C0026237
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	B:C0010749
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	B:C0026237
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	B:C0380051
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	B:C0599893
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	B:C0376669
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	B:C0291573
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	B:C0007585
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	B:C0026809
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	B:C0086418
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	B:C0227525
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	B:C0968383
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	B:C0380051
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	B:C0014432
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	B:C0383779
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	B:C1516312
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	B:C0074321
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	B:C0162638
in	O
primary	O
hepatocytes	O
.	O

Mechanistically	O
,	O
senecionine	O
induced	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
release	O
of	O
mitochondrial	O
cytochrome	O
c	I:C0010749
as	O
well	O
as	O
mitochondrial	O
JNK	O
translocation	O
and	O
activation	O
prior	O
to	O
the	O
increased	O
DNA	O
fragmentation	I:C0376669
and	O
caspase	O
-	I:C0291573
3	I:C0291573
activation	O
in	O
primary	O
cultured	O
mouse	O
and	O
human	O
hepatocyte	O
s.	O
SP600125	O
,	O
a	O
specific	O
JNK	O
inhibitor	O
,	I:C0014432
and	O
ZVAD	O
-	I:C0383779
fmk	I:C0383779
,	O
a	O
general	O
caspase	O
inhibitor	I:C1516312
,	O
alleviated	O
senecionine	O
-	O
induced	O
apoptosis	O
in	O
primary	O
hepatocytes	B:C0227525
.	O

Interestingly	O
,	O
senecionine	B:C0074321
also	O
caused	O
marked	O
mitochondria	O
fragmentation	I:C0230871
in	O
hepatocytes	O
.	O

Interestingly	O
,	O
senecionine	O
also	O
caused	O
marked	O
mitochondria	B:C0230871
fragmentation	I:C0230871
in	O
hepatocytes	O
.	O

Interestingly	O
,	O
senecionine	O
also	O
caused	O
marked	O
mitochondria	O
fragmentation	I:C0230871
in	O
hepatocytes	B:C0227525
.	O

Pharmacological	O
inhibition	B:C0021469
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	B:C0033684
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	B:C2755551
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	B:C0074321
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	B:C0230871
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	B:C0026237
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	B:C0010749
c	I:C0010749
and	O
apoptosis	O
.	O

Pharmacological	O
inhibition	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
(	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
)	O
,	O
a	O
protein	O
that	O
is	O
critical	O
to	O
regulate	O
mitochondrial	I:C2755551
fission	I:C2755551
,	O
blocked	O
senecionine	O
-	O
induced	O
mitochondrial	O
fragmentation	I:C0230871
and	O
mitochondrial	O
release	O
of	O
cytochrome	O
c	I:C0010749
and	O
apoptosis	B:C0162638
.	O

More	O
importantly	O
,	O
hepatocyte	B:C0227525
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	B:C0206745
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	B:C0074321
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	B:C0160390
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	B:C1096176
damage	I:C1096176
and	O
apoptosis	O
.	O

More	O
importantly	O
,	O
hepatocyte	O
-	O
specific	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
knockout	O
mice	I:C0206745
were	O
resistant	O
to	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
due	O
to	O
decreased	O
mitochondrial	O
damage	I:C1096176
and	O
apoptosis	B:C0162638
.	O

In	O
conclusion	O
,	O
our	O
results	O
uncovered	O
a	O
novel	O
mechanism	O
of	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
in	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
.	O

In	O
conclusion	O
,	O
our	O
results	O
uncovered	O
a	O
novel	O
mechanism	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	B:C0230871
fragmentation	I:C0230871
in	O
senecionine	O
-	O
induced	O
liver	O
injury	I:C0160390
.	O

In	O
conclusion	O
,	O
our	O
results	O
uncovered	O
a	O
novel	O
mechanism	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
in	O
senecionine	B:C0074321
-	O
induced	O
liver	O
injury	I:C0160390
.	O

In	O
conclusion	O
,	O
our	O
results	O
uncovered	O
a	O
novel	O
mechanism	O
of	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
in	O
senecionine	O
-	O
induced	O
liver	B:C0160390
injury	I:C0160390
.	O

Targeting	B:C1159372
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	B:C1957127
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	B:C0230871
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	B:C0162638
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	B:C0087111
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	B:C0235378
induced	O
by	O
Pyrrolizidine	O
alkaloids	I:C0034335
.	O

Targeting	O
dynamin	O
-	I:C1957127
related	I:C1957127
protein1	I:C1957127
-	O
mediated	O
mitochondrial	O
fragmentation	I:C0230871
and	O
apoptosis	O
may	O
be	O
a	O
potential	O
avenue	O
to	O
prevent	O
and	O
treat	O
hepatotoxicity	O
induced	O
by	O
Pyrrolizidine	B:C0034335
alkaloids	I:C0034335
.	O

